Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids
NCT04593745 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-10-22
Summary
Childhood ALL patients are treated with high dose steroids. The study will follow the intraocular pressure of children treated in according to an AIEOP-BFM protocol, during the induction phase that will be compared to the pressure before treatment. Potential risk factors for developing elevated intraocular pressure will be estimated.
Conditions
- ALL, Childhood
- Steroid-Induced Glaucoma
Interventions
- DEVICE
-
Intraocular pressure measurment
Intraocular pressure measurmentt using iCare devise: TONOPEN
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Shlomi Barzilai Birenboim · Schneider Children's Medical Hospital
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Month
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-09
- Primary Completion
- 2023-06-30
- Completion
- 2024-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
NCT04681417 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
NCT06184009 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
NCT03015844 ·Status: AVAILABLE
-
A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma
NCT04455139 ·Status: TERMINATED ·Phase: PHASE2
-
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
NCT00022035 ·Status: COMPLETED ·Phase: NA
-
Quality of Life in Children Cured of Retinoblastoma
NCT00278031 ·Status: UNKNOWN
-
Topotecan Episcleral Plaque for Treatment of Retinoblastoma
NCT04428879 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
NCT06257394 ·Status: RECRUITING ·Phase: PHASE2
-
Physical Activity in Acute Lymphoblastic Leukemia (ALL)
NCT06783738 ·Status: COMPLETED ·Phase: NA
-
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1
-
The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells
NCT06993766 ·Status: NOT_YET_RECRUITING
-
A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol
NCT04773366 ·Status: RECRUITING ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors
NCT03245450 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
NCT00148993 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
NCT02509234 ·Status: UNKNOWN
-
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
NCT05501899 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage
NCT01393769 ·Status: TERMINATED ·Phase: PHASE2
-
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
NCT00607984 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology of Infections in Pediatric Cancer Patients
NCT00934115 ·Status: UNKNOWN
-
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
NCT06235125 ·Status: RECRUITING ·Phase: PHASE1
-
Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
NCT04794296 ·Status: RECRUITING
-
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
NCT00566566 ·Status: UNKNOWN
-
Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis
NCT04032743 ·Status: UNKNOWN
-
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
NCT04037189 ·Status: UNKNOWN